MetaADEDB 2.0 @ LMMD
Lymphangiosis carcinomatosa
(UMLS:C0948588)
UMLS ID:
C0948588
MeSH ID:
N/A
Synonym(s)
1.
Lymphangiosis carcinomatosa
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1EverolimusFAERS: 13US FAERS
2GefitinibFAERS: 10OFFSIDES
US FAERS
3SorafenibFAERS: 8US FAERS
4osimertinibFAERS: 8US FAERS
5eribulinFAERS: 6US FAERS
6gemcitabineFAERS: 5US FAERS
7pazopanibFAERS: 5US FAERS
8CapecitabineFAERS: 4US FAERS
9Erlotinib HydrochlorideFAERS: 4OFFSIDES
US FAERS
10Abiraterone AcetateFAERS: 3US FAERS
11AfatinibFAERS: 3US FAERS
12DocetaxelFAERS: 3OFFSIDES
US FAERS
13olaparibFAERS: 3US FAERS
14regorafenibFAERS: 3US FAERS
15temsirolimusFAERS: 3US FAERS
16AnastrozoleFAERS: 2OFFSIDES
US FAERS
17LapatinibFAERS: 2US FAERS
18LetrozoleFAERS: 2US FAERS
19PaclitaxelFAERS: 2US FAERS
20PregabalinFAERS: 2US FAERS
21Sitagliptin PhosphateFAERS: 2US FAERS
22SunitinibFAERS: 2US FAERS
235-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amineFAERS: 1US FAERS
24AxitinibFAERS: 1US FAERS
25BosentanFAERS: 1US FAERS
26CH5424802FAERS: 1US FAERS
27CyclosporineFAERS: 1US FAERS
28DasatinibFAERS: 1US FAERS
29Erlotinib HydrochlorideFAERS: 1OFFSIDES
US FAERS
30EsomeprazoleFAERS: 1US FAERS
31FentanylFAERS: 1US FAERS
32Glatiramer AcetateFAERS: 1US FAERS
33Imatinib MesylateFAERS: 1US FAERS
34LevofloxacinFAERS: 1US FAERS
35LinezolidFAERS: 1US FAERS
36MaravirocFAERS: 1US FAERS
37MitomycinFAERS: 1OFFSIDES
US FAERS
38NorgestrelFAERS: 1US FAERS
39Olmesartan MedoxomilFAERS: 1US FAERS
40PemetrexedFAERS: 1OFFSIDES
US FAERS
41TacrolimusFAERS: 1US FAERS
42TolvaptanFAERS: 1US FAERS
43Zoledronic AcidFAERS: 1US FAERS
44ceritinibFAERS: 1US FAERS
45etonogestrelFAERS: 1US FAERS
46lenvatinibFAERS: 1US FAERS
47ribociclibFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
48Acetic acid;cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphateOFFSIDES
49AmbroxolOFFSIDES
50AmilorideOFFSIDES
51AmitriptylineOFFSIDES
52BezafibrateOFFSIDES
53CarboplatinOFFSIDES
54CarvedilolOFFSIDES
55ChlorpheniramineOFFSIDES
56ClomipramineOFFSIDES
57CodeineOFFSIDES
58DextromethorphanOFFSIDES
59DiltiazemOFFSIDES
60DomperidoneOFFSIDES
61ErtapenemOFFSIDES
62Hydrocortisone sodium succinateOFFSIDES
63IrinotecanOFFSIDES
64LosartanOFFSIDES
65Medroxyprogesterone AcetateOFFSIDES
66MeropenemOFFSIDES
67MisoprostolOFFSIDES
68MorphineOFFSIDES
69NabumetoneOFFSIDES
70OndansetronOFFSIDES
71Penicillin GOFFSIDES
72RabeprazoleOFFSIDES
73RamiprilOFFSIDES
74SpironolactoneOFFSIDES
75TremorineOFFSIDES
76TriazolamOFFSIDES
77TrimebutineOFFSIDES
78VinorelbineOFFSIDES
79azosemideOFFSIDES
80carbidopa, levodopa drug combinationOFFSIDES
81dexamethasone 21-phosphateOFFSIDES
82eperisoneOFFSIDES
83epinastineOFFSIDES
84eprazinoneOFFSIDES
85exemestaneOFFSIDES
86fudosteineOFFSIDES
87gemcitabineOFFSIDES
88geranylgeranylacetoneOFFSIDES
89itoprideOFFSIDES
90miglitolOFFSIDES
91mosaprideOFFSIDES
92nedaplatinOFFSIDES
93rebamipideOFFSIDES
94sennoside A&BOFFSIDES
95temocapril hydrochlorideOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.